1. Huang TC, Liang KH, Chang TJ, et al. (2024): Structure-based approaches against COVID-19. J Chin Med Assoc 87: 139-141.
2.
World Health Organization (2020): Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected: interim guidance, 13 March 2020.
3.
WHO (2024): World Health Data Platform – WHO 2024. Available from: https://www.who.int/data.
4.
Tuite NL, Lacey K (2013): Overview of invasive fungal infections. Methods Mol Biol 968: 1-23.
5.
Hoenigl M, Seidel D, Sprute R, et al. (2022): COVID-19-associated fungal infections. Nat Microbiol 7: 1127-1140.
6.
Chavda VP, Mishra T, Kamaraj S, et al. (2023): Post-COVID-19 fungal infection in the aged population. Vaccines (Basel) 11: 555.
7.
Takeuchi O, Akira S (2010): Pattern recognition receptors and inflammation. Cell 140: 805-820.
8.
Tsuboi H, Segawa S, Yagishita M, et al. (2022): Activation mechanisms of monocytes/macrophages in adult-onset Still disease. Front Immunol 13: 953730.
9.
Tone K, Stappers MHT, Willment JA, Brown GD (2019): C-type lectin receptors of the Dectin-1 cluster: Physiological roles and involvement in disease. Eur J Immunol 49: 2127-2133.
10.
Kalia N, Singh J, Kaur M (2021): The role of dectin-1 in health and disease. Immunobiology 226: 152071.
11.
Goodridge HS, Simmons RM, Underhill DM (2007): Dectin-1 stimulation by Candida albicans yeast or zymosan triggers NFAT activation in macrophages and dendritic cells. J Immunol 178: 3107-3115.
12.
Chiba S, Ikushima H, Ueki H, et al. (2014): Recognition of tumor cells by Dectin-1 orchestrates innate immune cells for anti-tumor responses. Elife 3: e04177.
13.
Drummond RA, Brown GD. The role of Dectin-1 in the host defence against fungal infections. Curr Opin Microbiol. 2011;14(4):392-9.
14.
Taylor PR, Tsoni SV, Willment JA, et al. (2007): Dectin-1 is required for beta-glucan recognition and control of fungal infection. Nat Immunol 8: 31-38.
15.
Uno A, Arima K, Shimazaki M, et al. (2021): A novel -glucan-oligonucleotide complex selectively delivers siRNA to APCs via Dectin-1. J Control Release 338: 792-803.
16.
Gringhuis SI, den Dunnen J, Litjens M, et al. (2009): Dectin-1 directs T helper cell differentiation by controlling noncanonical NF-kappaB activation through Raf-1 and Syk. Nat Immunol 10: 203-213.
17.
Colleselli K, Ebeyer-Masotta M, Neuditschko B, et al. (2023): Beyond pattern recognition: TLR2 promotes chemotaxis, cell adhesion, and migration in THP-1 cells. Cells 12: 1425.
18.
Chen SM, Zou Z, Qiu XR, et al. (2019): The critical role of Dectin-1 in host controlling systemic Candida krusei infection. Am J Transl Res 11: 721-732.
19.
Li F, Wang H, Li YQ, et al. (2023): C-type lectin receptor 2d forms homodimers and heterodimers with TLR2 to negatively regulate IRF5-mediated antifungal immunity. Nat Commun 14: 6718.
20.
Cunha C, Di Ianni M, Bozza S, et al. (2010): Dectin-1 Y238X polymorphism associates with susceptibility to invasive aspergillosis in hematopoietic transplantation through impairment of both recipient- and donor-dependent mechanisms of antifungal immunity. Blood 116: 5394-5402.
21.
Fischer M, Spies-Weisshart B, Schrenk K, et al. (2016): Polymorphisms of dectin-1 and TLR2 predispose to invasive fungal disease in patients with acute myeloid leukemia. PLoS One 11: e0150632.
22.
Żukowska A, Ciechanowicz A, Kaczmarczyk M, et al. (2023): Toll-like receptor polymorphisms (TLR2 and TLR4) association with the risk of infectious complications in cardiac surgery patients. Adv Clin Exp Med 32: 57-63.
23.
van der Velden WJFM, Plantinga T, Feuth T, et al. (2009): No impact of dectin-1 polymorphism Y238X on the outcome of hematopoietic stem cell transplantation, but a role for candida in acute graft-versus-host disease. Blood 114: 4498.
24.
Aghaei M, Khademi R, Far MAJ, et al. (2024): Genetic variants of dectin-1 and their antifungal immunity impact in hematologic malignancies: A comprehensive systematic review. Curr Res Transl Med 72: 103460.
25.
Alhabibi AM, Hassan AS, Abd Elbaky NM, et al. (2023): Impact of toll-like receptor 2 and 9 gene polymorphisms on COVID-19: Susceptibility, severity, and thrombosis. J Inflamm Res 16: 665-675.
26.
Bakaros E, Voulgaridi I, Paliatsa V, et al. (2023): Innate immune gene polymorphisms and COVID-19 prognosis. Viruses 15: 1784.
27.
Elgedawy GA, Elabd NS, Salem RH, et al. (2024): FURIN, IFNL4, and TLR2 gene polymorphisms in relation to COVID-19 severity: a case-control study in Egyptian patients. Infection 52: 2213-2229.
28.
Ten Oever J, Kox M, van de Veerdonk FL, et al. (2014): The discriminative capacity of soluble Toll-like receptor (sTLR)2 and sTLR4 in inflammatory diseases. BMC Immunol 15: 55.
29.
Kalia N, Kaur M, Sharma S, Singh J (2018): A comprehensive in silico analysis of regulatory SNPs of human CLEC7A gene and its validation as genotypic and phenotypic disease marker in recurrent vulvovaginal infections. Front Cell Infect Microbiol 8: 65.
30.
Faul F, Erdfelder E, Lang AG, Buchner A (2007): G* Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 39: 175-191.
31.
Cohen J (2013): Statistical power analysis for the behavioral sciences. Routledge.
32.
WHO (2020): Laboratory testing for coronavirus disease 2019 (COVID-19) in suspected human cases: interim guidance, 2 March 2020.
33.
Vianna JR, Pires Di Lorenzo VA, Simões MM, Jamami M (2017): Comparing the effects of two different levels of hyperoxygenation on gas exchange during open endotracheal suctioning: A randomized crossover study. Respir Care 62: 92-101.
34.
Pitt JI, Hocking AD, Pitt JI, Hocking AD (1997): Methods for isolation, enumeration and identification. Fungi and Food Spoilage; 21-57.
35.
Peng J, Wang Q, Mei H, et al. (2021): Fungal co-infection in COVID-19 patients: evidence from a systematic review and meta-analysis. Aging (Albany NY) 13: 7745-7757.
36.
Jung HE, Lee HK (2021): Current understanding of the innate control of toll-like receptors in response to SARS-CoV-2 infection. Viruses 13: 2132.
37.
Gonçalves SM, Pereira I, Feys S, et al. (2024): Integrating genetic and immune factors to uncover pathogenetic mechanisms of viral-associated pulmonary aspergillosis. mBio 15: e0198223.
38.
Negm EM, Mohamed MS, Rabie RA, et al. (2023): Fungal infection profile in critically ill COVID-19 patients: a prospective study at a large teaching hospital in a middle-income country. BMC Infect Dis 23: 246.
39.
Ferwerda B, Ferwerda G, Plantinga TS, et al. (2009): Human dectin-1 deficiency and mucocutaneous fungal infections. N Engl J Med 361: 1760-1767.
40.
Zhou P, Xie Y, Yan Z, et al. (2019): Association between dectin-1 gene single nucleotide polymorphisms and fungal infection: a systemic review and meta-analysis. Biosci Rep 39: BSR20191519.
41.
Plantinga TS, van der Velden WJ, Ferwerda B, et al. (2009): Early stop polymorphism in human DECTIN-1 is associated with increased candida colonization in hematopoietic stem cell transplant recipients. Clin Infect Dis 49: 724-732.
42.
Sainz J, Lupiáñez CB, Segura-Catena J, et al. (2012): Dectin-1 and DC-SIGN polymorphisms associated with invasive pulmonary Aspergillosis infection. PLoS One 7: e32273.
43.
Kumar A, Wang J, Esterly A, et al. (2023): Dectin-1 stimulation promotes a distinct inflammatory signature in the setting of HIV-infection and aging. Aging (Albany NY) 15: 7866-7908.